This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baumann, J. G.
Right arrow Articles by Salmons, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baumann, J. G.
Right arrow Articles by Salmons, B.

 Previous Article  |  Next Article 

Journal of Virology, September 1998, p. 7685-7687, Vol. 72, No. 9
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

CrFK Feline Kidney Cells Produce an RD114-Like Endogenous Virus That Can Package Murine Leukemia Virus-Based Vectors

Jörg G. Baumann,1,2 Walter H. Günzburg,1,2,* and Brian Salmons3

Institute of Virology, University of Veterinary Sciences, A-1210 Vienna, Austria,1 and Institute of Molecular Virology, GSF-Research Center for Environment and Health, D-85758 Oberschleissheim,2 and Bavarian Nordic Research Institute, D-80807 Munich,3 Germany

Received 20 April 1998/Accepted 8 June 1998

    ABSTRACT
Top
Abstract
Text
References

The feline kidney cell line CrFK is used extensively for viral infectivity assays and for study of the biology of various retroviruses and derived vectors. We demonstrate the production of an endogenous, RD114-like, infectious retrovirus from CrFK cells. This virus also is shown to efficiently package Moloney murine leukemia virus vectors.

    TEXT
Top
Abstract
Text
References

CrFK feline kidney cells have been used extensively both to propagate and to investigate the biology of a number of enveloped viruses, including retroviruses such as feline immunodeficiency virus (FIV) (1, 2, 6, 19, 21, 27, 32), feline leukemia virus (FeLV) (23), mouse mammary tumor virus (MMTV) (13, 20, 24), herpesviruses (7, 35), coronaviruses (3, 12), and feline syncytial virus (18). Further, retrovirus vectors based on MMTV (4, 25) and FIV (22) have been constructed with CrFK cells.

We investigated the production of type C retroviruses from CrFK cells which might play a role in the mobilization of transfected viral genes, other viruses, or viral vectors. For these studies, CrFK cells were obtained on two independent occasions from the American Type Culture Collection (CCL-94). With a 1:500 dilution of an antibody (goat anti-RD114 CA) specific for the capsid protein of RD114, the most common feline endogenous retrovirus (15), and a 1:1,000 dilution of secondary anti-goat alkaline phosphatase-conjugated antibody (Vector Laboratories, Burlingame, Calif.), a protein of 28 kDa, the expected size of the RD114 capsid protein (Fig. 1A), was detected in membrane extracts from noninfected parental CrFK cells (Fig. 1B, lane 5). Using the same antiserum, we also detected FeLV capsid protein (p26) (Fig. 1A) in feline embryonic fibroblasts (FEA) (10) infected with FeLV (Fig. 1B, lanes 2 and 3). This antiserum also detected Moloney murine leukemia virus (MuLV) Gag processing precursors (Fig. 1A) in CrFK cells transfected with an MuLV Gag-Pol expression construct (14) (Fig. 1B, lane 4). The lack of detectable proteins of 26 kDa or of processing intermediates in the parental CrFK cells (Fig. 1B, lane 5) suggests that the major type C retrovirus Gag protein produced is related to RD114.


View larger version (41K):
[in this window]
[in a new window]
  		FIG. 1.   (A) Schematic representation of the Gag proteins of FeLV, RD114, and MuLV. The sizes of the precursor proteins as well as the processed end products are shown. (B) Expression of RD114-related Gag proteins in QN10S cells (lane 1), FeLV-infected FEA cells (lanes 2 and 3), MuLV Gag-Pol-transfected CrFK cells (lane 4), and CrFK cells (lane 5) in membrane extracts with antiserum directed against the RD114 CA protein, after application of protein extract from 106 cells to a 7.5% sodium dodecyl sulfate-polyacrylamide gel, resolution at 40 V overnight, and transfer (2.5 mA/cm2, 1 h) to a nitrocellulose (Schleicher and Schüll) membrane (8). The size of the marker protein (30 kDa) is indicated, as is the RD114 Gag protein p28 and the FeLV Gag protein p26.

To investigate whether CrFK cells produce infective, RD114-related virions (CrLE virus), supernatant was taken from these cells and used to infect feline QN10S fibroblasts (9), previously shown not to express any RD114-related Gag proteins (Fig. 1B, lane 1). After passage of these initially infected QN10S cells for 4 days, viral proteins were extracted from 0.45-µm-pore-size-filtered 24-h supernatant from 5 × 106 cells and analyzed by Western blotting with the same antiserum directed against RD114 p28Gag. In contrast to the supernatant from noninfected QN10S cells (Fig. 2, lane 6), supernatant from QN10S cells infected with putative CrLE virus from CrFK cells (Fig. 2, lane 4) contained a 28-kDa protein with a mobility similar to that found in supernatant from CrFK cells, RD114-producing FER cells (Fig. 2, lane 1), and QN10S cells infected with RD114-containing supernatant (Fig. 2, lane 3). These results demonstrate the presence of infective, biologically active CrLE virus produced from CrFK cells.


View larger version (7K):
[in this window]
[in a new window]
  		FIG. 2.   Western blot analysis of viral proteins in supernatants from RD114-producing FER cells (lane 1), QN10S cells infected with RD114 (lane 3), QN10S cells infected with CrLE virus (lane 4), CrFK cells (lane 5), and QN10S cells (lane 6) with antiserum directed against the RD114 CA protein. The size of p28 Gag is indicated. Lane 2 is empty.

Infection of CrFK cells with an MuLV-based retrovirus vector, LXSN-EGFP, carrying neomycin resistance and enhanced green fluorescent protein genes (11) packaged in an amphotrophic packaging cell line, PA317 (17), allowed the establishment of neomycin (G418)-resistant, transduced CrFK clones. These were analyzed for the ability of the CrLE virus to provide helper functions in trans and to give rise to recombinant virus in which the LXSN-EGFP genomic RNA was packaged into CrLE Gag, Pol, and Env proteins. Two milliliters of 0.45-µm-pore-size-filtered 24-h supernatant from LXSN-EGFP-infected CrFK clones was used to infect 106 target mink lung cells (Mv1Lu) (5), known to be infectable with RD114 (28). After selection in 800 µg of G418 (Life Technologies) per ml, titers of around 105 CFU/ml were obtained (Table 1), similar to the titers obtained when the same cells were infected with LXSN-EGFP vector generated by a three-way transfection (29) of COS-7 cells (16) with the vector, an MuLV Gag-Pol expression construct (pGagpol-gpt) (14), and either an RD114 Env expression construct (pRDLF) (Table 1) or a vesicular stomatitis virus G (VSV-G) protein expression construct (pHCMV.G) (34) (Table 1). Thus, the CrLE infectious virus is able to package MuLV genomic RNA, as has been previously reported for RD114 (31).

                              
View this table:
[in this window]
[in a new window]
  		TABLE 1.   Titers of various viruses on mink lung cells

The receptor usage of the CrLE virus was determined by a receptor-interference assay. The same virus-containing supernatants described above were used to superinfect mink lung cells already productively infected with RD114 (MinkRD [provided by Yasuhiro Takeuchi]) and assayed either by neomycin resistance after G418 selection or by fluorescence-activated cell sorter (FACS) analysis for EGFP-positive cells (11). Only the VSV-G pseudotyped virus was able to infect these cells (Table 1), demonstrating that the CrLE virus utilizes the same receptor as RD114 (26).

Finally, the infection spectrum of the CrLE virus was investigated. As has already been reported for the RD114 virus (26), NIH 3T3 cells could not be infected with CrLE virus (Table 2), thus demonstrating that the virus is not contaminated by replication-competent, amphotropic MuLV. In contrast, rat XC cells (30), mink lung cells, and simian COS-7 cells could be infected by CrLE (Table 2). Interestingly, a titer was also sporadically recorded on CrFK cells, in two of five experiments (Table 2), suggesting either that not all CrFK cells produce CrLE virus or that not all receptor molecules are blocked. Early work by Lasfargues and colleagues (13) with immunofluoresence assays suggested that up to 5% of CrFK-F2 cells express RD114-related proteins. However, if these cells were producing infectious virus able to infect CrFK cells (ecotropic or amphotropic), we would expect the cells to rapidly become 100% infected. RD114 is known as a xenotropic virus, yet the closely related, if not identical, CrLE virus can infect the cell line from which it is produced, albeit inefficiently. RD114 has also been observed to occasionally infect feline cells (19a).

                              
View this table:
[in this window]
[in a new window]
  		TABLE 2.   Survey of infectivity of CrLE virusa

Our data demonstrate that CrFK cells produce an infectious virus which shares all tested properties with the RD114 virus. This virus is able to mobilize murine type C retroviruses by acting as a helper and, since it is an enveloped virus, is expected to form pseudotypes with other enveloped viruses (33). CrFK cells are commonly used both in classic diagnostic virology and in molecular virology. Thus, the possibility of mobilization of heterologous retroviral sequences, and potentially more importantly the possibility of generating pseudotyped virus with diagnostically relevant nonhuman pathogenic viruses, should be considered. Since we have shown that the CrLE virus can infect COS-7 cells and RD114 has been shown to infect other human cells (28), this could allow a normally host-restricted virus entry into human cells. Also, much of the biology of FIV, and to some extent MMTV, has been elucidated with CrFK cells. Indeed, CrFK is one of the few cell lines known to be permissive for production of MMTV (13, 20, 24). Although it is not clear whether the CrLE virus can act as a helper for FIV or type B viruses, the formation of pseudotypes may also contribute to infection (33). We have shown that MMTV virions produced in CrFK cells carry the MMTV envelope and core proteins (24) and that MMTV vectors give infectious titers on NIH 3T3 cells (4, 25), suggesting that the RD114 envelope was not involved in specifying the infection here. Even so, caution should be observed in the choice of cell lines as starting points for the generation of retrovirus packaging cell lines.

    ACKNOWLEDGMENTS

We thank Oswald Jarrett for the kind gift of FeLV-infected FEA cells, RD114-infected FER cells, QN10S cells, and RD114 CA antiserum. We also thank Yasuhiro Takeuchi for the gift of MinkRD cells and plasmid pRDLF, Jane C. Burns for plasmid pHCMV.G, Beate Sölkner for assistance with FACS analysis, and Jim Neil for helpful advice.

This work was supported in part by grants from the Bavarian Forschungsstiftung "FORGEN" program and by EC Biotechnology Grant BIO4-CT95-0100.

    FOOTNOTES

* Corresponding author. Mailing address: Institute of Virology, University of Veterinary Sciences, Josef-Baumann-Gasse 1, A-1210 Vienna, Austria. Phone: 43-1-25077-2301. Fax: 43-1-25077-2390. E-mail: walter.guenzburg{at}vu-wien.ac.at.

    REFERENCES
Top
Abstract
Text
References

1. Baldinotti, F., D. Matteucci, P. Mazzetti, C. Giannelli, P. Bandecchi, F. Tozzini, and M. Bendinelli. 1994. Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system. J. Virol. 68:4572-4579[Abstract/Free Full Text].
2. Bandecchi, P., M. Pistello, D. Matteucci, S. Lombardi, M. Bendinelli, and F. Tozzini. 1995. Examination of variables affecting syncytium formation by, and serum neutralization of, feline immunodeficiency virus on CrFK cells. New Microbiol. 18:241-252[Medline].
3. Evermann, J. F., J. L. Heeney, A. J. McKeirnan, and S. J. O'Brien. 1989. Comparative features of a coronavirus isolated from a cheetah with feline infectious peritonitis. Virus Res. 13:15-27[Medline].
4. Günzburg, W. H., and B. Salmons. 1986. Mouse mammary tumour virus mediated transfer and expression of neomycin resistance to infected cultured cells. Virology 155:236-248[Medline].
5. Henderson, I. J., M. M. Lieber, and G. J. Todaro. 1974. Mink cell line Mv1 Lu (CCL-64). Focus formation and the generation of "nonproducer" transformed cell lines with murine and feline sarcoma viruses. Virology 60:282-287[Medline].
6. Hosie, M. J., N. Broere, J. Hesselgesser, J. D. Turner, J. A. Hoxie, J. C. Neil, and B. J. Willett. 1998. Modulation of feline immunodeficiency virus infection by stromal cell-derived factor. J. Virol. 72:2097-2104[Abstract/Free Full Text].
7. Ikeda, Y., Y. Kawaguchi, Y. Inoshima, M. Kohmoto, M. Shimojima, G. Inada, E. Sato, C. Kai, T. Miyazawa, and T. Mikami. 1997. The effects of treatment with chemical agents or infection with feline viruses on protein-binding properties of the feline immunodeficiency virus long terminal repeat. Virus Res. 51:203-212[Medline].
8. Janka, I., W. H. Günzburg, G. Brem, V. Erfle, and B. Salmons. 1993. Sub-retroviral particles as gene transfer vectors that by-pass retrovirus receptor interaction restrictions. Biochem. Mol. Biol. Int. 31:349-357[Medline].
9. Jarrett, O., and J.-P. Ganiere. 1996. Comparative efficacy studies with a recombinant feline leukaemia virus vaccine. Vet. Rec. 138:7-11[Abstract/Free Full Text].
10. Khan, K. N., G. J. Kociba, M. L. Wellman, and J. A. Reiter. 1992. Cytotoxicity in feline leukemia virus subgroup-C infected fibroblasts is mediated by adherent bone marrow mononuclear cells. In Vitro Cell. Dev. Biol. 28A:260-266.
11. Klein, D., S. Indraccolo, K. von Rombs, A. Amadori, B. Salmons, and W. H. Günzburg. 1997. Rapid identification of viable retrovirus transduced cells using the green fluorescent protein as a marker. Gene Ther. 4:1256-1260[Medline].
12. Klumperman, J., J. K. Locker, A. Meijer, M. C. Horzinek, H. J. Geuze, and P. J. Rottier. 1994. Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding. J. Virol. 68:6523-6534[Abstract/Free Full Text].
13. Lasfargues, E. Y., A. B. Vaidya, J. C. Lasfargues, and D. H. Moore. 1976. In vitro susceptibility of mink lung cells to the mouse mammary tumor virus. J. Natl. Cancer Inst. 57:447-449.
14. Markowitz, D., S. Goff, and A. Bank. 1988. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 62:1120-1124[Abstract/Free Full Text].
15. McAllister, R. M., M. Nicolson, M. B. Gardner, R. W. Rongey, S. Rasheed, P. S. Sarma, R. J. Huebner, M. Hatanaka, S. Oroszlan, R. V. Gilden, A. Kabigting, and L. Vernon. 1972. C-type virus released from cultured human rhabdomyosarcoma cells. Nat. New Biol. 235:3-6[Medline].
16. Mellon, P., V. Parker, Y. Gluzman, and T. Maniatis. 1981. Identification of DNA sequences required for transcription of the human alpha 1-globin gene in a new SV40 host-vector system. Cell 27:279-288[Medline].
17. Miller, A. D., and C. Buttimore. 1986. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6:2895-2902[Abstract/Free Full Text].
18. Miyazawa, T., S. Itagaki, K. Tomonaga, Y. Ikeda, T. Mori, Y. Kawaguchi, T. Gemma, Y. Tohya, M. Mochizuki, and T. Mikami. 1995. Establishment of carrier-state infection of a feline renal cell line with feline syncytial virus. J. Vet. Med. Sci. 57:65-69[Medline].
19. Miyazawa, T., Y. Kawaguchi, M. Kohmoto, J. Sakuragi, A. Adachi, M. Fukasawa, and T. Mikami. 1992. Production of feline immunodeficiency virus in feline and non-feline non-lymphoid cell lines by transfection of an infectious molecular clone. J. Gen. Virol. 73:1543-1546[Abstract/Free Full Text].
19a. Neil, J. Personal communication.
20. Nusse, R., H. Janssen, L. de Vries, and R. Michalides. 1980. Analysis of secondary modifications of mouse mammary tumor virus proteins by two-dimensional gel electrophoresis. J. Virol. 35:340-348[Abstract/Free Full Text].
21. Pancino, G., S. Castelot, and P. Sonigo. 1995. Differences in feline immunodeficiency virus host cell range correlate with envelope fusogenic properties. Virology 206:796-806[Medline].
22. Poeschla, E. M., F. Wong-Staal, and D. J. Looney. 1998. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat. Med. 4:354-357[Medline].
23. Rojko, J. L., C. M. Cheney, P. W. Gasper, K. L. Hamilton, E. A. Hoover, L. E. Mathes, and G. J. Kociba. 1986. Infectious feline leukaemia virus is erythrosuppressive in vitro. Leuk. Res. 10:1193-1199[Medline].
24. Salmons, B., B. Groner, C. M. Calberg-Bacq, and H. Ponta. 1985. Production of mouse mammary tumor virus upon transfection of a recombinant proviral DNA into cultured cells. Virology 144:101-114[Medline].
25. Salmons, B., S. Moritz-Legrand, I. Garcha, and W. H. Günzburg. 1989. Construction and characterization of a packaging cell line for MMTV-based retroviral vectors. Biochem. Biophys. Res. Commun. 159:1191-1198[Medline].
26. Schnitzer, T. J., R. A. Weiss, D. K. Juricek, and F. H. Ruddle. 1980. Use of vesicular stomatitis virus pseudotypes to map viral receptor genes: assignment of RD114 virus receptor gene to human chromosome 19. J. Virol. 35:575-580[Abstract/Free Full Text].
27. Siebelink, K. H., J. A. Karlas, G. F. Rimmelzwaan, A. D. Osterhaus, and M. L. Bosch. 1995. A determinant of feline immunodeficiency virus involved in Crandell feline kidney cell tropism. Vet. Immunol. Immunopathol. 46:61-69[Medline].
28. Sommerfelt, M. A., and R. A. Weiss. 1990. Receptor interference groups of 20 retroviruses plating on human cells. Virology 176:58-69[Medline].
29. Soneoka, Y., P. M. Cannon, E. E. Ramsdale, J. C. Griffiths, G. Romano, S. M. Kingsman, and A. J. Kingsman. 1995. A transient 3-plasmid expression system for the production of high-titer retroviral vectors. Nucleic Acids Res. 23:628-633[Abstract/Free Full Text].
30. Svoboda, J. 1960. Presence of chicken tumour virus in the sarcoma of the adult rat inoculated after birth with Rous sarcoma tissue. Nature 186:980-981[Medline].
31. Takeuchi, Y., G. Simpson, R. G. Vile, R. A. Weiss, and M. K. Collins. 1992. Retroviral pseudotypes produced by rescue of a Moloney murine leukemia virus vector by C-type, but not D-type, retroviruses. Virology 186:792-794[Medline].
32. Verschoor, E. J., L. A. Boven, H. Blaak, A. L. W. van Vliet, M. C. Horzinek, and A. de Ronde. 1995. A single mutation within the V3 envelope neutralization domain of feline immunodeficiency virus determines its tropism for CRFK cells. J. Virol. 69:4752-4757[Abstract].
33. Weiss, R. A. 1993. Cellular receptors and viral glycoproteins involved in retrovirus entry, p. 1-72. In J. A. Levy (ed.), The retroviridae, vol. 2. Plenum, New York, N.Y.
34. Yee, J. K., T. Friedmann, and J. C. Burns. 1994. Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol. 43:99-112.
35. Yokoyama, N., K. Maeda, Y. Kawaguchi, M. Ono, Y. Tohya, and T. Mikami. 1995. Construction of the recombinant feline herpesvirus type 1 deleted thymidine kinase gene. J. Vet. Med. Sci. 57:709-714[Medline].

Journal of Virology, September 1998, p. 7685-7687, Vol. 72, No. 9
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baumann, J. G.
Right arrow Articles by Salmons, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baumann, J. G.
Right arrow Articles by Salmons, B.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»